Beijing Hotgen Biotech Co

Beijing Hotgen Biotech Co Interest Coverage

The Interest Coverage Ratio of Beijing Hotgen Biotech Co (688068.SS) as of Nov 5, 2026 is -8.10. In the previous year, Interest Coverage Ratio was 1.16 — a change of -797.92% (lower).

Interest Coverage

-8.10

YoY

-797.92%

Last updated:

Interest Coverage Ratio of Beijing Hotgen Biotech Co is 2024 -8.10 . Interest Coverage Ratio of Beijing Hotgen Biotech Co was 2023 1.16 . It decreases by -797.92% lower compared to the previous year.

The Beijing Hotgen Biotech Co Interest Coverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Interest Coverage
Date
Interest Coverage
Jan 1, 2017
26.61 CNY
Jan 1, 2018
42.93 CNY
Jan 1, 2019
10.15 CNY
Jan 1, 2020
13.19 CNY
Jan 1, 2021
120.41 CNY
Jan 1, 2022
24.13 CNY
Jan 1, 2023
1.16 CNY
Jan 1, 2024
-8.10 CNY
The Beijing Hotgen Biotech Co Interest Coverage history
YEARInterest CoverageYoY
-8.10-797.92%
1.16-95.19%
24.13-79.96%
120.41+812.82%
13.19+29.98%
10.15-76.36%
42.93+61.30%
26.61—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Beijing Hotgen Biotech Co Stock analysis

What does Beijing Hotgen Biotech Co do? Beijing Hotgen Biotech Co., Ltd. generates revenue through the development and manufacturing of in-vitro diagnostic, point-of-care-testing, and biodefense products. The firm's product portfolio primarily consists of in vitro diagnostic reagents, in vitro diagnostic instruments, and biological raw materials. These offerings are designed to address clinical needs in areas such as liver cancer, hepatitis, cardiovascular and cerebrovascular diseases, and inflammatory infections. Additionally, the products serve public safety applications including biosafety, food safety, and disease control and emergency response. The company operates in both domestic and overseas markets, selling its solutions to entities involved in clinical healthcare and public safety sectors. By providing specialized diagnostic tools and biological materials, Beijing Hotgen Biotech Co., Ltd. supports medical diagnosis and emergency response efforts globally. The business model relies on the direct sale of these manufactured goods to customers who require advanced diagnostic capabilities for disease detection and safety monitoring. Beijing Hotgen Biotech Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Beijing Hotgen Biotech Co stock

Interest Coverage Ratio of Beijing Hotgen Biotech Co is -8.10 in 2024.

Interest Coverage Ratio of Beijing Hotgen Biotech Co changed from 1.16 to -8.10, representing a -797.92% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Interest Coverage Ratio Beijing Hotgen Biotech Co since 2006 – with annual values, charts, and detailed analysis.

The Interest Coverage ratio measures a company's ability to pay interest on its debt. Higher ratios indicate greater financial strength and lower default risk.

Interest Coverage = EBIT / Interest Expense

A 'good' varies by industry and company stage. On Eulerpool, you can compare Interest Coverage Ratio's Beijing Hotgen Biotech Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Beijing Hotgen Biotech Co

All Key Metrics — Beijing Hotgen Biotech Co